Newsletter

000250 - Samchundang Pharm

000250 Summary
Biopharma
Stock Price & Overview
₩157,000 +1,600 (+1.03%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩157,000  ≈ US$112  ·  Market cap ₩3.7tn (≈ $2.6bn)
What kstock news is. Short items on what actually happened — a filing, an order, a buyback, a result — written from the Korean filing or the Korean press for people who cannot read either. Each one puts the event against a figure from this company's own statements. No view, no rating; that is what analysis is for.

000250 News

All kstock news »

No news written yet.

0 items. Written from DART filings and Korean press reports; every item lists its source.

Similar to 000250

SymbolLast Price
000100Yuhan Corporation₩81,400
+0.0%
028300HLB Co., Ltd.₩33,750
+2.9%
298380ABL Bio Inc.₩71,400
+5.6%
087010Peptron, Inc.₩157,300
+7.3%
141080LigaChem Biosciences Inc.₩92,000
+4.2%
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.